KRAS G12C Inhibitors Breaking the 40-Year Drug Development Barrier Check out our extensive video library (see channel for our latest videos) Introduction KRAS G12C inhibitors represent a historic milestone in the field of oncology, marking the first successful attempt to therapeutically target
Tag: JDQ443
